glp 1 for binge eating disorder Navigating GLP-1 use in therapy GLP-1 obesity drugs and eating

Potential compensation in a Victoza lawsuit may include: Victoza lawsuits involve serious allegations of gastrointestinal injury, pancreatitis, and other medical complications that may leave patients facing long-term health consequences and substantial financial losses

Rates of severe nausea or vomiting were reported in 3 to 8 percent of GLP-1 users, but confirmed gastroparesis diagnoses requiring gastric emptying studies were extremely rare

Bruemmer notes that the medications are well accepted by patients

Many people describe the drugs effects not simply as appetite suppression, but as a quieting of persistent food noise. But as clinical trials expand and preclinical research continues, evidence is accumulating that these medications exert much broader physiological effects than previously thought